Suitability of icteric index (II) as front-line test for the identification of blood samples with abnormal total bilirubin (TB) concentrations;Impiego dell'indice itterico come esame di primo livello per l'identificazione dei campioni con concentrazioni anormali di bilirubinemia

Biochimica Clinica

Volumn 39, Issue 4, 2015, Pages 270-274

  Pasqualetti, Sara ^a   Szoke, Dominika ^a   Panteghini, Mauro ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN;

ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD SAMPLING; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; HEMATOLOGICAL PARAMETERS; HUMAN; ICTERIC INDEX; IMMUNOASSAY ANALYZER; LINEAR REGRESSION ANALYSIS; PREDICTIVE VALUE; PREVALENCE; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

EID: 84943229756     PISSN: 03930564     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Guder WG, Fonseca-Wollheim FD, Heil W, et al. The haemolytic, icteric and lipemic sample recommendations regarding their recognition and prevention of clinically relevant interferences. J Lab Med 2000;24:357-64.
2. Dimeski G. Interference testing. Clin Biochem Rev 2008;29(suppl 1):S43-8.
3. CLSI. Hemolysis, icterus, and lipemia/turbidity indices as indicators of interference in clinical laboratory analysis; Approved guideline. CLSI document C56-A. Clinical and Laboratory Standards Institute, 2012.
4. Architect system operations manual PN 201837-111. Sample interference indices (c System), section 3-25. September 2013. Available at https://www.abbottdiagnostics.com/registration-ous/login
5. Glick MR, Ryder KW, Glick SJ, et al. Unreliable visual estimation of the incidence and amount of turbidity, hemolysis, and icterus in serum from hospitalized patients. Clin Chem 1989;35:837-9.
6. Simundic AM, Nikolac N, Ivankovic V, et al. Comparison of visual vs. automated detection of lipemic, icteric and hemolyzed specimens: can we rely on a human eye? Clin Chem Lab Med 2009;47:1361-5.
7. Lippi G, Banfi G, Buttarello M, et al. per il Gruppo di Studio Intersocietario SIBioC-SIMeL-CISMEL "Variabilita extraanalitica del dato di laboratorio". Raccomandazioni per la rilevazione e la gestione dei campioni non idonei nei laboratori clinici. Biochim Clin 2007;31:216-24.
8. Mozzi R, Carnevale A, Valente C, et al. Rilevazione, monitoraggio e trattamento di non conformita nella fase preanalitica: l'esperienza di un ospedale universitario metropolitano. Biochim Clin 2013;37:95-9.
9. Salinas M, Lopez-Garrigos M, Lugo J, et al. Diagnostic accuracy of icteric index to detect abnormal total bilirubin values. J Clin Pathol 2012;65:928-33.
10. Szo{double acute}ke D, Braga F, Valente C, et al. Measurement of icteric index as approach to detect abnormal total bilirubin values. J Clin Pathol 2013;66:1095-7.
11. Fevery J. Bilirubin in clinical practice: a review. Liver Int 2008;28:592-605.
12. Salinas M, Lopez-Garrigos M, Asencio A, et al. Laboratory utilization improvement through a computer-aided algorithm developed with general practitioners. Clin Chem Lab Med 2014, DOI: 10.1515/cclm-2014-0762. [Epub ahead of print]
13. Mayer M. Association of serum bilirubin concentration with risk of coronary artery disease. Clin Chem 2000;46:1723-7.
14. Darby D, Broomhead C. Interference with serum indices measurement, but not chemical analysis, on the Roche Modular by Patent Blue V. Ann Clin Biochem 2008;45:289-92.
15. McTaggart MP, Cannon LP, Kearney EM. Effect of Patent Blue V(®) dye on sample interference indices on the Abbott Architect. Ann Clin Biochem 2012;49:510-1.
16. Dolci A, Panteghini M. Harmonization of automated hemolysis index assessment and use: is it possible? Clin Chim Acta 2014;432:38-43.